MAIA- Maia Biotechnology, Inc.

Over the past 90 days, insiders at Maia Biotechnology, Inc. (MAIA) have been net buyers, picking up 258,078 shares worth roughly $352K on balance.

MAIA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Vitoc Vlad	1.05M	$1.44M	-
Other	Himmelreich Jeffrey C	60.0K	-	-
Other	Gryaznov Sergei	46.5K	$62.6K	-
Dir	Louie Ngar Yee	39.6K	-	-
Dir	Smith Stan	38.9K	-	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 14, 2026	Vitoc Vlad	Chief Executive Officer	Buy	73,000	$1.37	$100,010.00	+7.5%	-	-
Sep 10, 2026	Guerrero Ramiro	Director	Buy	37,595	$1.32	$49,516.37	+5.1%	-	-
Aug 28, 2026	Guerrero Ramiro	Director	Buy	133,790	$1.38	$184,103.30	+22.2%	-	-
Aug 24, 2026	Guerrero Ramiro	Director	Buy	1,794	$1.33	$2,386.02	+0.3%	-	-
Aug 20, 2026	Guerrero Ramiro	Director	Buy	11,899	$1.37	$16,301.63	+2.0%	-	-
Jun 1, 2026	Gryaznov Sergei	Chief Scientific Officer	Buy	2,000	$1.35	$2,690.00	+4.5%	-	-
Jun 1, 2026	Smith Stan	Director	Buy	75,000	$1.34	$100,200.00	+5.2%	-	-
Jun 1, 2026	Vitoc Vlad	Chief Executive Officer	Buy	72,700	$1.39	$100,885.79	+8.0%	-	-
Dec 22, 2025	Smith Stan	Director	Buy	57,189	$1.22	$69,999.34	+4.2%	+12.0%	-
Dec 22, 2025	Chaouki Steven M59	Director	Buy	40,849	$1.22	$49,999.18	+36.8%	+12.0%	-